R Ritch1. 1. Department of Ophthalmology, New York Eye and Ear Infirmary, New York, USA.
Abstract
PURPOSE: To synthesize recent findings regarding pigment dispersion syndrome in order to arrive at a hypothesis concerning the nature of an underlying genetic predisposition. METHODS: The literature on the subject was reviewed and analyzed. RESULTS: Eyes with pigment dispersion syndrome differ from normal in that they have a larger iris, a midperipheral posterior iris concavity that increases with accommodation, a more posterior iris insertion, increased iridolenticular contact that is reversed by inhibition of blinking, possibly an inherent weakness of the iris pigment epithelium, and an increased incidence of lattice degeneration of the retina. CONCLUSION: A gene affecting some aspect of the development of the middle third of the eye early in the third trimester appears at the present time to be the most likely cause.
PURPOSE: To synthesize recent findings regarding pigment dispersion syndrome in order to arrive at a hypothesis concerning the nature of an underlying genetic predisposition. METHODS: The literature on the subject was reviewed and analyzed. RESULTS: Eyes with pigment dispersion syndrome differ from normal in that they have a larger iris, a midperipheral posterior iris concavity that increases with accommodation, a more posterior iris insertion, increased iridolenticular contact that is reversed by inhibition of blinking, possibly an inherent weakness of the iris pigment epithelium, and an increased incidence of lattice degeneration of the retina. CONCLUSION: A gene affecting some aspect of the development of the middle third of the eye early in the third trimester appears at the present time to be the most likely cause.
Authors: Adrian A Lahola-Chomiak; Tim Footz; Kim Nguyen-Phuoc; Gavin J Neil; Baojian Fan; Keri F Allen; David S Greenfield; Richard K Parrish; Kevin Linkroum; Louis R Pasquale; Ralf M Leonhardt; Robert Ritch; Shari Javadiyan; Jamie E Craig; W T Allison; Ordan J Lehmann; Michael A Walter; Janey L Wiggs Journal: Hum Mol Genet Date: 2019-04-15 Impact factor: 6.150
Authors: Colleen M Trantow; Tryphena L Cuffy; John H Fingert; Markus H Kuehn; Michael G Anderson Journal: Invest Ophthalmol Vis Sci Date: 2011-01-05 Impact factor: 4.799
Authors: Anamika Tandon; Ze Zhang; John H Fingert; Young H Kwon; Kai Wang; Wallace L M Alward Journal: Am J Ophthalmol Date: 2019-02-21 Impact factor: 5.258
Authors: Colleen M Trantow; Mao Mao; Greg E Petersen; Erin M Alward; Wallace L M Alward; John H Fingert; Michael G Anderson Journal: Invest Ophthalmol Vis Sci Date: 2008-11-21 Impact factor: 4.799
Authors: Michael G Anderson; Norman L Hawes; Colleen M Trantow; Bo Chang; Simon W M John Journal: Pigment Cell Melanoma Res Date: 2007-06-28 Impact factor: 4.693